Page 8 - Astrazeneca

US says it will share 60 million AstraZeneca vaccine doses with world

The inoculation is used around the world but has not yet been authorised by the US Food and Drug Administration.

EU sues AstraZeneca over breach of coronavirus vaccine supply contract

AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court

EU launches legal action against AstraZeneca over vaccine contract

AstraZeneca allegedly failed to respect the terms of its contract with the EU

Pressure on Biden admin to ship AstraZeneca vaccine, supplies to India

Congresswoman Rashida Talib tweeted that the Covid-19 crisis in India is a harsh reminder that the pandemic is not over until the whole world is safe

Even a single vaccine dose cuts Covid-19 infection rate, new UK study finds

A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65%

Astrazeneca is yellow, Pfizer green: Hungary's Covid vaccine-themed treats

At a patisserie in the small town of Vere­segyhaz, the choice is between a selection of layered mousses with colourful jelly toppings, presented in small glasses, with decorative syringes on top

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

AstraZeneca could have Covid-19 vaccine against variant by 2021 end

Walters blamed challenges - including delivery delays for the AstraZeneca shot in the European Union - on the "complex process" of producing a vaccine

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Govt push to step up Covid-19 vaccine output 10 times by September

Bharat Biotech and 3 PSEs to ramp up Covaxin production capacity

Europe has surpassed 1 million deaths from Covid-19 pandemic, says WHO

Dr Hans Kluge also said the risk of people suffering blood clots is far higher for people with Covid-19 than people who receive AstraZeneca's coronavirus vaccine.

US weighs next steps for J&J virus shot amid clot mystery

U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who received Johnson&Johnson's COVID-19 vaccine a one-dose shot that many countries were eagerly awaiting to help speed virus protection. It's not clear if the exceedingly rare reports so far, six cases out of more than 7 million inoculations in the U.S. really are linked to the J&J vaccine. But the government recommended a pause in J&J vaccinations on Tuesday, just a week after European regulators declared that such clots are a rare but possible risk with the AstraZeneca vaccine, a shot made in a similar way but not yet approved for use in the U.S. The clots occurred in strange places, in veins that drain blood from the brain, and in people with abnormally low levels of clot-forming platelets. The six cases raised an alarm bell because that number is at least three times more than experts would have expected to see even of more typical brain-drainage clots, said

EU not to renew AstraZeneca, J&J Covid-19 vaccine contracts on expiry

A spokesman for the EU Commission said it was keeping all options open to be prepared for the next stages of the pandemic, for 2022 and beyond

In world first, Denmark ditches AstraZeneca's coronavirus vaccine

Many countries in Europe and elsewhere have resumed administering the shot, with some restricting its use to certain age groups, mostly those aged above 50 or above 60.

Canada will change AstraZeneca license terms if issues emerge: Patty Hajdu

Canadian health regulators will not hesitate to change the terms of the AstraZeneca coronavirus vaccine license if additional safety issues emerge, Health Minister Patty Hajdu said

India fast-tracks emergency use of foreign-made Covid-19 vaccines

No need for prior local clinical trials for vaccines cleared by regulators

Right prescription

Fast-tracking of vaccine approvals is a welcome policy change

India becomes 60th nation to approve Sputnik V Covid-19 vaccine: Russia

Sputnik V, developed by Moscow's Gamaleya Institute, has proved 91.6% effective against Covid-19

India's Covid crisis stems from arrogance, hyper-nationalism, incompetence

Regulatory uncertainty, bullying, and contempt for legitimate profit-making is familiar to every entrepreneur in India.

Australia drops vaccine rollout target amid concerns about AstraZeneca shot

Australia last week said it is guiding against giving the AstraZeneca vaccine to people under the age of 50.